<div class="raw-html-embed"><a href="https://libratech.ai/ch/?utm_source=partner&amp;utm_medium=website&amp;utm_campaign=wkch_libra_prsp_staempfli_07_2026
">Stämpfli Fachinhalte - jetzt im rechtssicheren Libra All-In-One AI Workspace verfügbar - Jetzt kostenlos testen!</a></div>

Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Aboverträge Kündigen

Résiliation d’abonnement

Vertrag widerrufen

Résiliation de contrat 

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

Libra

Was ist Libra?

C'est quoi Libra ?

Kostenlos testen

Tester gratuitement

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Aktienrecht

Droit des sociétés anonymes

Publikationen

Publications

Literatur

Digitales Angebot

Bücher

Livres

Buchreihen

Collections

Onlinemodule LEXIA

Modules en ligne LEXIA

recht.ch

Studienliteratur

Littérature pour les études

Dienstleistungen

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Trevino R: Patent Smarter

Patent Smarter

An Inventor's Guide to Saving Time, Money & Headaches

Focusing on cultural expressions that are most likely to intermingle with copyright law, trademark and IP-adjacent regulations, this book examines contemporary issues in technology, intellectual property law, and culture.

Focusing on cultural expressions that are most likely to intermingle with copyright law, trademark and IP-adjacent regulations, this book examines contemporary issues in technology, intellectual property law, and culture.

The Tangification of Intangible Cultural Heritage

Technology, Intellectual Property Law and Culture

Patent Damages

The book applies values and concepts from Global Administrative Law (GAL) to international patent law, demonstrating how limiting technocratic and overly economic language can be. It will be of interest to researchers in the field of patent law, international law and administrative law.

Values, Principles, and Challenges

Patents and Global Administrative Law

This book investigates the institutionalized process, basic laws, and evolutionary trends of the patent system based on the analytical model of evolutionary theory and deploying a historical and comparative approach.

This book investigates the institutionalized process, basic laws, and evolutionary trends of the patent system based on the analytical model of evolutionary theory and deploying a historical and comparative approach.

The Transition of the Patent System

Routledge Research in Health Law

This book examines the potential for regionalization of intellectual property law and policy as a means of improving pharmaceutical access for least developed countries. It takes the East African Community as a case study of developing and least developed countries to illustrate why and how a regional collective approach is preferred.

A Holistic Approach for Least Developed Countries

Regional Cooperation, Intellectual Property Law and Access to Medicines

IP Protection in China, Second Edition

This invaluable treatise, in 31 chapters and two volumes, breaks down strategic reasoning behind every phase of patent infringement litigation, from prelitigation issues and initial client counseling through the filing of the Notice of Appeal. The book explores the perspectives and strategies of both patent owners and patent challengers, providing updates on the most recent trends in patent litigation and winning strategies from some of the country's leading attorneys.Reflecting on Yale Professor William Robinson's 1890 three-volume treatise on patents, a federal judge once observed that little has changed in the grand framework of patent law. However, while the view from above may seem unchanged, the ground-level realities of patent litigation have undergone profound transformation. This field has been continually reshaped by an array of forces, from sweeping Supreme Court decisions echoing through lower courts to the growing intricacies of emerging technologies such as artificial intelligence, IoT, and biopharmaceuticals. Patent litigation continues to change and evolve, spurred on by challenges presented by patentability, non-practicing entities, and influential procedures in Texas and Delaware courts. The Federal Circuit, now deeply divided, has accepted its first en banc utility patent case in six years, while Section 101 persists as a contentious and uncertain area in both case law and legislative proposals. The post-TC Heartland landscape, developments in PTAB practices, and the impact of arbitration have further redefined the litigation process. Against this backdrop, our contributors offer insights from the most respected leaders at the bar and bench, sharing expertise and perspectives on these pressing topics and more.

Patent Litigation Strategies Handbook, Fifth Edition

Representing a compromise in the pharmaceutical industry in balancing patent exclusivity against market competition, the effect of the Drug Price Competition and Patent Term Restoration Act (commonly known as the Hatch-Waxman Act) on controlling the pharmaceutical market remains unsettled. Amendments to the original act included provisions for an abbreviated process for FDA approval of generic versions of patented pharmaceuticals through the filing of an Abbreviated New Drug Application (ANDA) and the right to initiate patent litigation against an applicant. This law has resulted in ANDA litigation cases and a constant struggle to shape the landscape of the patent and regulatory regime governing FDA approved patented and generic drugs. The Hatch-Waxman Act with it amendments is a hybrid of two already complex areas of the law -- U.S. patent law and FDA regulatory law--which makes patent litigation in this area especially complicated and hotly contested.Now updated and expanded, this Fourth Edition of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators is a comprehensive guide examining the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law in the context of Paragraph IV ANDA litigation. In 23 detailed chapters, this single-source reference focuses both on the current and developing law as well as the strategies and tactics employed by the litigants.ANDA Litigation provides both a ready roadmap for novice litigators in the field as well as more detailed material and strategy to assist the more experienced ANDA litigator. The first part details the Hatch-Waxman Act and how it was implemented. Practical tools in these chapters include: an overview of the drug approval process, including required notice and pre-litigation considerations, and issues related to the timeline of litigation. Following this, the authors explore even deeper into the actual litigation under the act, with topics covering: responses to the complaint, discovery, the work of experts, and patent claim construction and summary judgment.Further chapters are practice-focused, covering issues including preparing the case for trial, the work of trial, managing the litigation process, and post-trial issues, including appeals to the U.S. Court for the Federal Circuit. Finally, the authors discuss remedies, settlement, and antitrust implications, and the book also includes chapters on regulation and litigation of pharmaceuticals outside the U.S.

Strategies and Tactics for Pharmaceutical Patent Litigators, Fourth Edition

Anda Litigation

Routledge Studies in Cultural Heritage and International Law

The book examines whether the protection of Intangible Cultural Heritage (ICH) by Indonesia and Malaysia upheld the interests of the various communities from which the cultural heritage originates, and whether the laws recognise that cultural heritage is often shared with other states and communities.

Perspectives from Indonesia and Malaysia

Legal Protection of Intangible Cultural Heritage

This is a guide to translating the language of patents and how to avoid costly translation errors, errors which might hinder the examination process for granting patents, or that might make patents undefendable in a context of litigation. The identified provisions of law govern language uses, right down to the use of punctuation.

This is a guide to translating the language of patents and how to avoid costly translation errors, errors which might hinder the examination process for granting patents, or that might make patents undefendable in a context of litigation. The identified provisions of law govern language uses, right down to the use of punctuation.

Translating the Language of Patents

Invention Analysis and Claiming: A Patent Lawyer's Guide, Third Edition, presents a comprehensive approach to analyzing inventions and capturing them in a sophisticated set of patent claims. A central theme is the importance of using the problem-solution paradigm to identify the "inventive concept" before the claim-drafting begins. The book's teachings are grounded in "old school" principles of patent practice that, before now, have been learned only on the job from supervisors and mentors.Like the second edition, this revision discusses functional language in patent claims and the use of "means-plus-function" claim elements. New chapters for the third edition delve into questions of patentability under 35 USC 101, 102, and 103. One of the new chapters focuses on the chaotic state of the case law vis-à-vis the unpatentability of abstract ideas, while another challenges the reader to argue both for and against the obviousness of some two dozen now commonplace innovations, like the salad spinner and the window envelope. Questions at the end of each chapter help the reader to: <ul><li>confirm the reader's understanding of the principles presented</li><li>explore the jurisprudential and practical implications of those principles; and</li><li>try out the invention analysis and claim drafting skills taught in the chapter.</li></ul>

A Patent Lawyer's Guide, Third Edition

Invention Analysis and Claiming

Breaking the Medicine Monopolies is a lawyer’s personal narrative of the events that led to the widespread use of low-cost generic drugs and the current drug price crisis. Breaking the Medicine Monopolies is a personal narrative about Alfred Engelberg’s fifty years of legal work in the drug industry. He takes you inside the mysterious world of patents to provide a basic understanding of how drug makers have gamed the laws governing brand and generic competition, misused patents to prolong monopolies, and delayed generic competition on old drugs instead of focusing on discovering new ones. In this book, Engelberg provides readers with an understanding of how the growing use of low-cost generic drugs led to the highest prices in the world for new drugs, and how middlemen in the drug distribution chain have exploited a lack of price transparency in order to earn excessive profits. Breaking the Medicine Monopolies is a must-read for anyone who wants to understand how ill-considered policy decisions and an inept patent system led to unaffordable prices for new drugs, and what can be done to correct the problem.

Reflections of a Generic Drug Pioneer

Breaking the Medicine Monopolies

Patent Smarter

Weitere Titel zum Thema